Publication of annual report for financial year 2023
Annual Shareholders' Meeting resolutions include approval of revised Remuneration Policy and (re)appointment of Board members
Extraordinary Shareholders' Meeting resolutions include approval of renewal of authorized capital and issuance of Gilead Subsequent Warrant B
Mechelen, Belgium; 28 March 2024, 21.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) today publishes its annual report for the financial year 2023 and announces its Annual and Extraordinary Shareholders' Meetings (AGM and EGM) to be held sequentially on Tuesday, 30 April 2024 at 2:00 pm (CET) and 3:00 pm (CET), respectively, at the registered office of the Company.
The annual report for the financial year 2023, including a review of figures and performance, is available online at and can also be downloaded as PDF. Our annual 2023 Form 20-F filing with the SEC is available at www.sec.gov/edgar.
Galapagos has the honor to invite its shareholders, holders of subscription rights, Board members, and statutory auditor to its Annual (ordinary) and Extraordinary Shareholders' Meetings that will be held sequentially on Tuesday 30 April 2024 at 2:00 pm (CET) and 3:00 pm (CET), respectively, at the Company's registered office.
The items on the agenda of the Annual and Extraordinary Shareholders' Meetings include, amongst other items: (i) the approval of a revised Remuneration Policy, (ii) the reappointment of Dr. Elisabeth Svanberg as Non-Executive Independent Director, (iii) the appointments of Dr. Susanne Schaffert and Mr. Simon Sturge as Non-Executive Independent Directors, and Mr. Andrew Dickinson as Non-Executive Director, (iv) the approval of the issuance of a warrant for the benefit of Gilead Therapeutics A1 Unlimited Company ("Subsequent Warrant B"), and (v) the approval of the renewal of the Company's authorized capital by up to 20% of the share capital.
In order to be admitted to the Shareholders' Meetings to be held on 30 April 2024, the holders of securities issued by the Company must comply with article 7:134 of the Belgian Code of Companies and Associations and article 23 of the Company's articles of association, and fulfil the formalities described in the convening notice. The convening notice and other documents pertaining to the Annual and Extraordinary Shareholders' Meetings can be consulted on our website.
Biographies of proposed Board members
The biographies of Dr. Elisabeth Svanberg, Dr. Susanne Schaffert, Mr. Simon Sturge and Mr. Andrew Dickinson can be found on our website.